General
Preferred name
CANERTINIB
Synonyms
CANERTINIB DIHYDROCHLORIDE ()
PD-0183805, PD-183805, Canertinib Dihydrochloride, CI-1033, SN-26606 ()
PD-183805 ()
CI-1033 ()
CI-1033 dihydrochloride ()
PD-183805 dihydrochloride ()
Canertinib (CI-1033) ()
CI 1033 ()
Canertinib (dihydrochloride) ()
PD183805 ()
CI-1033 dihydrochloride, PD-183805 dihydrochloride ()
Canertinib hydrochloride ()
SN-26606 ()
PD-0183805-002B ()
PD-0183805 ()
Canertinib (hydrochloride) ()
P&D ID
PD003440
CAS
267243-28-7
289499-45-2
Tags
drug candidate
covalent binder
probe
available
Drug indication
Lymphoma
Drug Status
investigational
Max Phase
Phase 3
Probe info
Probe selectivity
protein-selective
Probe type
P&D approved
calculated probe
experimental probe
Probe targets
[[ compound.targets[t].gene_name ]]
Probe control
Orthogonal probes
114
No orthogonal probes found
Similar probes
11
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Canertinib is an irreversible inhibitor which blocks signal transduction through all four members of the erbB family .
(GtoPdb)
MOA
Covalent Inhibitor
(Chemical Probes.org)
DESCRIPTION
Investigated for use/treatment in breast cancer and lung cancer.
(PKIDB)
DESCRIPTION
inhibitor of EGFR and HER2
(Informer Set)
DESCRIPTION
Potent and selective PI 3-kinase p110delta inhibitor
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
10
Organisms
0
Compound Sets
28
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Chemical Probes.org
Clinical kinase drugs
Concise Guide to Pharmacology 2017/18
Drug Repurposing Hub
DrugBank
DrugMAP
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
High-quality chemical probes
Informer Set
LSP-MoA library (Laboratory of Systems Pharmacology)
LSP-OptimalKinase library (Laboratory of Systems Pharmacology)
NPC Screening Collection
PKIDB
Probe Miner (suitable probes)
ReFrame library
Selleckchem Bioactive Compound Library
Tocris Bioactive Compound Library
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
45
Molecular Weight
485.16
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
9
Ring Count
4
Aromatic Ring Count
3
cLogP
4.39
TPSA
88.61
Fraction CSP3
0.29
Chiral centers
0.0
Largest ring
6.0
QED
0.34
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
EGFR
ERBB2
HER2/ErbB2
AKT1, EGFR, ERBB2, ERBB4
Orthopoxvirus
EGFR,HER2
EGFR, ERBB2
Compound status
clinical
Targets
EGFR,ERBB2
Pathway
Angiogenesis
JAK/STAT Signaling
Tyrosine Kinase/Adaptors
Anti-infection
Protein Tyrosine Kinase/RTK
MOA
EGFR inhibitor
Inhibitor
Orthogonal probe
Afatinib
Target subclass
RTK
RTK, RTK
Target class
Protein kinase
Kinase, Kinase
Therapeutic Class
Anticancer Agents
Source data
